Cas:1353658-81-7 Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) manufacturer & supplier

Chemical Name:Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II)

CAS.NO:1353658-81-7

Synonyms:Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II)

Molecular Formula:C₃₀H₄₂ClNPPd+₂

Molecular Weight:589.507941

HS Code:

Physical and Chemical Properties:

Melting point:244-246 °C

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) Use and application,Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) technical grade,usp/ep/jp grade.

Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) manufacturer Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) supplier It is frequently associated with the presence of blasts or leukemic cells in the marrow. Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) factory Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.